As used in this report, each of the terms "we," "us," "our," the "Company" and
"Simulations Plus" refers to Simulations Plus, Inc. and its wholly owned
subsidiaries Cognigen Corporation, of Buffalo, New York, and DILIsym Services,
Inc of Research Triangle Park, North Carolina, unless otherwise stated or the
context otherwise requires.
OVERVIEW
Simulations Plus, Inc., incorporated in 1996, is a premier developer of
groundbreaking drug discovery and development software for mechanistic modeling
and simulation, for machine-learning-based prediction of properties of molecules
solely from their structure, and is exploring the application of its
machine-learning technologies in other industries, including aerospace/military
and general healthcare. Our pharmaceutical/chemistry software is licensed to
major pharmaceutical, biotechnology, agrochemical, and food industry companies
and to regulatory agencies worldwide for use in the conduct of industry-based
research.